Events & Training

Lab Innovations 2018

31 October 2018 - 01 November 2018

Lab Innovations is the UK’s only trade exhibition dedicated to the laboratory industry and attracts laboratory professionals who are looking for the latest innovations and services. It is the nation’s largest gathering of laboratory manufacturers and suppliers, making it an important event for powering the business of Science. Supported by some of the UK’s top science institutions it has fast become the event to attend for the laboratory industry.

NEC, North Ave, Marston Green, Birmingham B40 1NT

Lab Innovations

31 October 2018 - 01 November 2018

Lab Innovations is the UK’s only event dedicated to the laboratory industry. It is the nation’s largest gathering of laboratory manufacturers, suppliers and professionals, and with the support of some of the UK’s top science institutions it has fast become the laboratory event to attend. As an attendee you’ll be met by a line-up of over 135 leading suppliers showcasing their latest products, services and innovative new technologies. Every year 100's of products are launched at lab innovations offering you the opportunity to get first access to cutting edge solutions. The event is complemented by a free-to-attend programme of inspiring seminars, engaging show features and numerous networking opportunities, with well-known science commentators Maggie Philbin and Steve Mould headlining the Royal Society of Chemistry theatre.

National Exhibition Centre, Birmingham, UK

Protein & Antibody Engineering Summit

12 November 2018 - 16 November 2018

EGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2017, for the sixth year in a row, a record number of delegates participated in PEGS Europe, as more than 900 attendees from 35 countries convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. The 2018 event will feature: 1,000 attendees 225 technical presentations 150+ scientific posters Dedicated networking opportunities Exclusive exhibit & poster viewing hours Interactive roundtable, breakout & panel discussions

Lisbon Congress Centre, Lisbon, Portugal

Superbugs & Superdrugs USA Conference

12 November 2018 - 13 November 2018

SMi’s 3rd annual Superbugs & Superdrugs conference returns to New Jersey, on the 12th-13th November 2018. The issue of antibacterial resistance is becoming increasingly prevalent within the world of modern medicine. Difficult-to-treat pathogens create an incredibly real issue within clinical environments; and the problem needs to be addressed with novel treatments and the development of mechanisms which circumvent current therapeutic barriers. To address the ever-growing need of information on the AMR issues, SMi’s 3rd annual Superbugs & Superdrugs conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers, within the field. • Gain insight into Diagnostic Technologies being used in the field and the futuristic developments which could be implemented. • Network with key industry leaders and benefit from though provoking discussions • Hear from the main regulatory bodies to advise on guidelines surrounding funding and development • Listen to up-and-coming companies, developing novel approaches to circumvent antibacterial resistance • Discover new approaches of anti-fungal development

Renaissance Woodbridge Hotel, New Jersey, USA

Inv€$tival 2018 Home - Biotech and Money

13 November 2018

LSX (formerly Biotech and Money) connects corporates to capital and the Inv€$tival Showcase is our most direct way of showcasing the latest innovative and investable private and public life science opportunities to our investor network. In exclusive partnership with Jefferies LLC, the Inv€$tival Showcase spans 4-tracks and will feature the most exciting companies across key sub-sectors within life sciences, including immuno-oncology, neuroscience & CNS, cell and gene therapies, digital health and medtech. The global list of presenting companies will include the most exciting and innovative, as well as investable, companies looking to raise capital or profile with investors; brought together through both LSX's and Jefferies' investor networks.

Hilton Waldorf, London, UK

ELRIG Pharmaceutical Flow Cytometry & Imaging 2018

14 November 2018 - 15 November 2018

The 6th biennial Pharmaceutical Flow Cytometry and Imaging meeting will be held at GlaxoSmithKline, Stevenage, UK. Flow cytometry and imaging are two powerful technology platforms that enable high-content analysis of physiologically-relevant cell systems and pre-clinical and clinical biomarkers. Since our first meeting in 2008, we have seen the technology develop and the applications widen across many areas of industrial and academic drug discovery and development. This meeting will focus on the application of Flow Cytometry and Imaging to illuminate biology from the single cell to the patient. We aim to bring together the research community working in the field of flow cytometry and imaging with interests in developing and applying the technology for pharmaceutical research. Join scientists from pharma, biotech, CROs and academia to hear talks given by speakers at the cutting edge of cytometry, take part in commercial vendor lab-based workshops, network at the exhibition, innovation forum and speakers dinner and gain strategic insights into solutions for increasing the success of drug discovery and development.

GlaxoSmithKline, Stevenage, UK

Biosimilars USA 2018

14 November 2018 - 15 November 2018

Building on the success of previous events, SMi proudly announces the return of its 5th Annual Biosimilars USA Conference, taking place in New Jersey on the 14th and 15th November 2018. This fifth annual event will gather a global audience of biosimilar experts and industry-thought leaders to discuss biosimilar manufacturing and commercialization considerations specific to the U.S. Fresh from the press: On March 7th, 2018, the U.S.-FDA’s Commissioner, Scott Gottlieb, MD, announced that Biosimilar medicines are now a top priority for the FDA. Join us this November to learn how to take advantage of the FDA’s focus on biosimilars, accelerate your biosimilar pipeline and achieve FDA approval. Hear from a selection of carefully handpicked keynote addresses and case studies presented to you by top manufacturing and leading distributors of market approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations. This event is CPD accredited. #SMiBioSimUSA

Renaissance Woodbridge Hotel, New Jersey, USA

Lyophilization USA Conference

15 November 2018 - 16 November 2018

SMi’s 4th annual Lyophilization USA Conference will look toward the future of lyophilization. Some notable areas of interest have been new technologies and developments within lyophilization, challenges and unmet needs in lyophilization, regulatory challenges and validation of lyophilized products, scale-up and transfer and alternatives beyond conventional lyophilization methods. Topics on discussion at the Lyophilization USA Conference include: • Continuous freeze-drying technologies • Developments in bulk lyophilization technology • How to overcome challenges in lyophilization of high concentrated solutions and high density biologic materials • Process optimization of lyophilization from a regulatory perspective • Strategies to validate the lyophilization process • Methods beyond lyophilization: Spray drying, foam drying and microwave drying • Use of artificial intelligence in lyophilization

Renaissance Woodbridge Hotel, New Jersey, USA

Ophthalmic Drugs

26 November 2018 - 27 November 2018

SMi's 2nd annual Ophthalmic Drugs conference returning to London, takes place at the Copthorne Tara Hotel in Kensington, on the 26th - 27th November 2018. As the global population ages, the incidence of ophthalmic disorders continues to grow, and thus the interest of pharmaceutical and biotech companies is increasingly focused towards innovation of novel approaches for the development of ophthalmic drugs, driving the growth of the global ophthalmic drug market, which is projected to reach £30 billion by 2023. Building on last year’s success, this must-attend conference will bring together industry experts to discuss and analyse the latest advancements and challenges within ophthalmic drug development and delivery. Some notable areas of interest have been neuroprotection in ophthalmology, advancements in gene therapy, AMD clinical trial updates, and novel approaches for delivery of ocular drugs. The two-day event will also feature two interactive, half-day post-conference workshops on 28th November 2018, led by twoXAR and Aston University

Copthorne Tara Hotel, London, UK

ICI Europe

27 November 2018 - 29 November 2018

Rather than covering a random selection of immuno-oncology combinations, 4th Annual ICI Europe Summit focuses on how checkpoint combinations can impact every stage of the cancer immunity cycle, enhancing the long-term success of immuno-oncology drug development. Cutting through the noise and hype around the immuno-oncology field, this industry focused conference will use the cancer immunity cycle as a framework from which to investigate the most promising immuno-oncology approaches.

The Sofitel Berlin Kurfuerstendamm, Berlin, Germany